DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

11083	Companies
243222	Keywords
171386	Articles
130955	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 6 months ago

DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de BLA du patch Viaskin® Peanut chez les enfants de 4-7 ans, accélérant ainsi au premier semestre 2026 le dépôt de la demande…
DBV Technologies conclut un accord avec la FDA sur les données d'innocuité du patch Viaskin Peanut, anticipant un dépôt au 1er semestre 2026, et publie ses résultats financiers 2024

Résultats Financiers FDA DBV Technologies Viaskin Peanut Innocuité
PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 6 months ago

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
DBV Technologies secures FDA agreement for Viaskin Peanut Patch BLA submission in 4-7-year-olds, accelerating launch timeline by approximately one year. Unaudited 2024 financial results reported

FDA Agreement DBV Technologies Unaudited Financial Results Viaskin Peanut Patch BLA Submission
BRIEF

published on 02/25/2025 at 22:06, 1 year 6 months ago

DBV Technologies au congrès AAAAI/WAO pour présenter des avancées sur l'allergie à l'arachide

Étude Clinique DBV Technologies Allergie À L'arachide Patch VIASKIN® Congrès AAAAI/WAO
BRIEF

published on 02/25/2025 at 22:06, 1 year 6 months ago

DBV Technologies at AAAAI/WAO Congress to Present Advances in Peanut Allergy

Clinical Study DBV Technologies Peanut Allergy AAAAI/WAO Congress VIASKIN® Patch
PRESS RELEASE

published on 02/25/2025 at 22:01, 1 year 6 months ago

DBV Technologies participera au prochain congrès conjoint AAAAI/WAO
DBV Technologies participera au prochain congrès conjoint AAAAI/WAO en présentant les résultats de l'étude sur l'immunothérapie épicutanée avec VIASKIN® peanut pour les enfants allergiques à l'arachide

Immunothérapie DBV Technologies Viaskin Peanut Congrès Conjoint AAAAI/WAO
PRESS RELEASE

published on 02/25/2025 at 22:01, 1 year 6 months ago

DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
DBV Technologies to participate in AAAAI/WAO Joint Congress to present long-term efficacy results of epicutaneous immunotherapy with VIASKIN peanut patch in peanut-allergic children aged 4-11 years, showcasing treatment benefits and high compliance rates

DBV Technologies Epicutaneous Immunotherapy Viaskin Peanut Patch AAAAI/WAO Joint Congress PEPITES Study
BRIEF

published on 01/13/2025 at 22:10, 1 year 8 months ago

Bilan de Liquidité Semestriel de DBV Technologies

Contrat De Liquidité ODDO BHF Transactions Boursières DBV Technologies VIASKIN®
BRIEF

published on 01/13/2025 at 22:10, 1 year 8 months ago

DBV Technologies Half-Yearly Liquidity Statement

Liquidity Contract ODDO BHF Stock Market Transactions DBV Technologies VIASKIN®
PRESS RELEASE

published on 01/13/2025 at 22:05, 1 year 8 months ago

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
DBV Technologies publie le bilan semestriel de son contrat de liquidité avec ODDO BHF. Détails des transactions et volumes échangés. Focus sur le patch VIASKIN® pour les allergies alimentaires

Contrat De Liquidité ODDO BHF DBV Technologies Allergies Alimentaires Patch VIASKIN®
PRESS RELEASE

published on 01/13/2025 at 22:05, 1 year 8 months ago

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
DBV Technologies issues Half-Year Report on liquidity contract with ODDO BHF, revealing assets in the account and transaction details

Liquidity Contract Half-year Report Biopharmaceutical Company ODDO BHF DBV Technologies

Accesswire

Published on 09/25/2026 at 15:00, 58 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/25/2026 at 14:00, 1 hour 58 minutes ago

Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich
Published on 09/25/2026 at 13:00, 2 hours 58 minutes ago

Core Silver Announces Grant of Stock Options
Published on 09/25/2026 at 13:00, 2 hours 58 minutes ago

American Hotel Income Properties REIT LP Announces Corporate Update
Published on 09/25/2026 at 13:00, 2 hours 58 minutes ago

UraniumX Plans Winter Gravity Program at Murphy Lake as Q4 Assays Approach

View all ACCESSWIRE

EQS Group

Published on 09/25/2026 at 15:37, 21 minutes ago

EQS-Adhoc: RAG-Stiftung: RAG-Stiftung regarding a potential takeover of Evonik by BASF
Published on 09/25/2026 at 15:30, 28 minutes ago

Les dirigeants africains appellent à renforcer le financement national et l'action multisectorielle pour accélérer l'élimination du paludisme
Published on 09/25/2026 at 15:30, 28 minutes ago

African leaders call for stronger domestic financing and multisectoral action to accelerate malaria elimination
Published on 09/25/2026 at 15:12, 46 minutes ago

EQS-Adhoc: Evonik Industries AG confirms receipt of a non-binding approach from BASF SE regarding a potential takeover offer
Published on 09/25/2026 at 14:58, 1 hour ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

Les Echos

Published on 09/25/2026 at 07:00, 8 hours 58 minutes ago

ENGIE mobilise une aide exceptionnelle de 54 millions d'euros pour soutenir les ménages les plus fragiles face à la hausse des prix de l'énergie
Published on 09/24/2026 at 18:31, 21 hours 26 minutes ago

LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:10, 21 hours 48 minutes ago

Financial statements - 30 june 2026
Published on 09/24/2026 at 18:00, 21 hours 58 minutes ago

GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 21 hours 58 minutes ago

GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026

View all LES ECHOS COMFI WIRE